Cargando…
Normalization cancer immunotherapy: blocking Siglec-15!
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6473001/ https://www.ncbi.nlm.nih.gov/pubmed/31016034 http://dx.doi.org/10.1038/s41392-019-0045-x |
_version_ | 1783412337060872192 |
---|---|
author | Cao, Guangchao Xiao, Zhiqiang Yin, Zhinan |
author_facet | Cao, Guangchao Xiao, Zhiqiang Yin, Zhinan |
author_sort | Cao, Guangchao |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-6473001 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-64730012019-04-23 Normalization cancer immunotherapy: blocking Siglec-15! Cao, Guangchao Xiao, Zhiqiang Yin, Zhinan Signal Transduct Target Ther Research Highlight Nature Publishing Group UK 2019-04-19 /pmc/articles/PMC6473001/ /pubmed/31016034 http://dx.doi.org/10.1038/s41392-019-0045-x Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Research Highlight Cao, Guangchao Xiao, Zhiqiang Yin, Zhinan Normalization cancer immunotherapy: blocking Siglec-15! |
title | Normalization cancer immunotherapy: blocking Siglec-15! |
title_full | Normalization cancer immunotherapy: blocking Siglec-15! |
title_fullStr | Normalization cancer immunotherapy: blocking Siglec-15! |
title_full_unstemmed | Normalization cancer immunotherapy: blocking Siglec-15! |
title_short | Normalization cancer immunotherapy: blocking Siglec-15! |
title_sort | normalization cancer immunotherapy: blocking siglec-15! |
topic | Research Highlight |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6473001/ https://www.ncbi.nlm.nih.gov/pubmed/31016034 http://dx.doi.org/10.1038/s41392-019-0045-x |
work_keys_str_mv | AT caoguangchao normalizationcancerimmunotherapyblockingsiglec15 AT xiaozhiqiang normalizationcancerimmunotherapyblockingsiglec15 AT yinzhinan normalizationcancerimmunotherapyblockingsiglec15 |